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Properties of cathepsin L from rat liver lysosomes were compared with those of a similar enzyme, cathepsin 
S from beef spleen. Major characteristics of cathepsin L are the high activity against Z-Phe-Arg-methylcou- 
marylamide and sensitivity to the fast reacting irreversible inhibitor Z-Phe-Phe-diazomethane. In contrast, 
cathepsin S hydrolyzes Z-Phe-Arg-methylcoumarylamide only slowly and Z-Phe-Phe-diazomethane cannot 
be regarded as a potent inhibitor of this enzyme. The differences in the substrate specificity of cathepsin 
L from rat liver and cathepsin S from beef spleen are discussed in comparison with the substrate specificity 
of cathepsin B from rat and human liver and beef spleen. 
Substrate specificity Enzyme differentiation Cysteine proteinase Cathepsin B Cathepsin L Cathepsin S 
1. INTRODUCTION 
Our purpose is to consider whether a cysteine 
proteinase that has been isolated from bovine 
spleen should be regarded as a variant of cathepsin 
L, or a new enzyme. This enzyme was initially call- 
ed beef spleen cathepsin S [l], because of its 
similarity to beef lymph node cathepsin S [2], and 
then cathepsin L [3]. 
The criteria for identification of the lysosomal 
cysteine proteinases are by no means settled. For 
cathepsin B, the availability of the specific 
substrates Z-Arg-Arg-NNap and Z-Arg-Arg-NMec 
is important [4], but as yet we have no specific 
substrate for cathepsin L. Nevertheless, studies of 
rat [5,6], rabbit [7] and human [8] cathepsin L 
have shown that important characteristics are high 
proteolytic activity, high activity against Z-Phe- 
Arg-NMec at low substrate concentrations, and 
rapid irreversible inactivation by Z-Phe-Phe- 
Abbreviations: Bz-, benzoyl; -CHNz, diazomethane; 
E-64, L-3-carboxy-trans-2,3-epoxypropyl-L-leucylami- 
do(4-guanidino)butane; -NMec, 7-(4-methyl)coumaryl- 
amide; -NNap, 2-naphthylamide; -NNapOMe, 2-(4-me- 
thoxy)naphthylamide; Z-, benzyloxycarbonyl 
CHN2. With these properties in mind, we have re- 
examined the beef spleen enzyme, which we 
describe as cathepsin S. 
2. MATERIALS AND METHODS 
E-64 was kindly provided by Dr A.J. Barrett, 
Strangeways Research Laboratory, Cambridge. 
Azocasein was prepared from casein, vitamin-free 
(Serva, Heidelberg), by Dr J. Langner, Physiol.- 
them. Institut, Halle (Saale), GDR. (Characteriza- 
tion of the azocasein preparation is given below.) 
Z-Phe-Phe-CHNz and Z-Phe-Ala-CHNz were 
kindly given by Dr E. Shaw, Brookhaven National 
Laboratory, Upton, NY. Bz-Arg-NNap and Bz- 
Arg-NH2 were obtained from Serva. Z-Arg-Arg- 
NNapOMe and Z-Arg-Arg-NMec were from 
Bachem, Torrance, CA, and Z-Phe-Arg-NMec 
and Bz-Phe-Val-Arg-NMec were obtained from 
Cambridge Research Biochemicals, Cambridge. 
2.1. Enzyme preparation 
Cathepsin B from human liver was kindly pro- 
vided by Dr A.J. Barrett, Strangeways Research 
Laboratory. Cathepsins B and L were purified 
from rat liver lysosomes as in [5,9] and stored in 
Published by Elsevier Science Publishers B. V. 
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0.1 M acetate buffer (pH 5.0) containing 0.5 mM 
HgClz and 1 mM NazEDTA. Cathepsins B and S 
from beef spleen were purified as in [lo]. 
2.2. Enzyme assays 
The final concentrations of substrates were: 
peptide-NMec, 10pM; peptide-NNap, 1 mM; Bz- 
Arg-NH2, 10 mM; azocasein, 1%. 
(After termination of the incubation the azoca- 
sein concentration was 0.5% in 5% trichloroacetic 
acid and AE&s”,m = 20 after total hydrolysis and 
E&S,,, = 0.05-0.1 for the blank have been deter- 
mined using this azocasein preparation.) The reac- 
tion mixtures were buffered at pH 6.0 with 50 mM 
phosphate buffer, at pH 5.5 and 5.0 with 0.1 M 
acetate buffer. The enzymes were generally ac- 
tivated 5 min at 40°C with 2.5 mM dithiothreitol 
and 2.5 mM NazEDTA prior to incubation with 
the substrates. The incubation time was 10 min for 
the peptides as substrates and 30 min for 
azocasein. 
The assays with all substrates were generally as 
in [4]. 
2.3. Determination of enzyme concentration 
The enzyme concentrations were determined by 
active-site titration with E-64 as detailed in [4]. In 
these assays Z-Phe-Arg-NMec was used as 
substrate to determine the concentrations of 
cathepsin L, cathepsin S and cathepsin B. 
3. RESULTS 
Table 1A shows the activities against several 
substrates of preparations of rat cathepsin L and 
beef cathepsin S that had been standardized by ac- 
tive site titration. The data can be compared with 
Table 1 
Activities of cathepsins L, S and B 
(A) Cathepsins L and S 
Substrate PH Cathepsin L 
rat liver 
Cathepsin S 
beef spleen 
Azocasein 6.0 259 343 
Azocasein-urea 5.0 710 967 
Z-Phe-Arg-NMec 5.5 1229 71 
Bz-Phe-Val-Arg-NMec 5.5 67 120 
Z-Arg-Arg-NMec 5.5 2.4 0.3 
Bz-Arg-NH2 5.5 94 9 
(B) Cathepsins B from 3 species 
Substrate PH 
Rat liver 
Cathepsin B from 
Human liver Beef spleen 
Azocasein 6.0 29 35 35 
Azocasein-urea 5.0 9 10 8 
Z-Phe-Arg-NMec 6.0 400 554 700 
Bz-Phe-Val-Arg-NMec 6.0 294 412 479 
Z-Arg-Arg-NMec 6.0 367 414 552 
Z-Arg-Arg-NNapOMe 6.0 2856 8960 9352 
Bz-Arg-NNap 6.0 288 389 468 
1 unit corresponds to 1 mg azocasein and 1 pmol peptide, respectively, degraded per min at 40°C. The concentration 
of the enzymes was determined by titration with E-64. Substrate concentration in the assays was 10 gM for the NMec 
substrates, 1 mM for the NNap substrates, 10 mM for Bz-Arg-NH2 and 1% of azocasein. Concentration of urea was 
3 M in the assay mixtures. Values are expressed as units//lmol 
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those for cathepsin B from 3 different species in Z-Arg-Arg-NMec is a highly selective substrate 
table 1B. Cathepsin L and cathepsin S showed ap- for cathepsin B, but we have repeatedly detected 
proximately similar levels of proteolytic activity traces of activity (less than 1%) in cathepsin L 
against azocasein that were much higher than those preparations; this is reflected in the data of table 1. 
of cathepsin B. It has been shown that cathepsin L The activity is not due to contaminating cathepsin 
is much more stable to 3 M urea at pH 5.0 in the B, since it is very sensitive to inhibition by Z-Phe- 
presence of azocasein than is cathepsin B [ 111. Phe-CHN2 (not shown). Cathepsin S did not show 
Since the urea sensitizes the azocasein to pro- any activity significant within the limits of ex- 
teolysis, it makes the assays more sensitive to perimental error against this substrate. Bz-Arg- 
cathepsin L, but less sensitive to cathepsin B, since NH2 is a low-M, substrate that is hydrolysed by rat 
it is destroyed. It can be seen that cathepsin S cathepsin L [5]. Z-Phe-Arg-NMec has been 
resembled cathepsin L and differed from cathepsin detected as a very sensitive substrate of the enzyme 
B in this type of assay. We detected almost no ac- [6]. However, these are only poor substrates of 
tivity of cathepsin L or cathepsin S against Bz-Arg- beef cathepsin S (table 1). The molar activity of 
NNap (<O. 1 unit/pmol) and Arg-NNap was not cathepsin L with Bz-Arg-NH2 is about IO-fold and 
hydrolysed at all (not shown). with Z-Phe-Arg-NMec about 17-fold higher than 
Table 2 
Relative activities of cathepsins L, S and B 
Substrate Cathepsin 
L Sbecf B ra, rat 
Z-Phe-Arg-NMec 100.0 100.0 100.0 
Z-Arg-Arg-NMec 0.2 0.4 91.8 
Bz-Phe-Val-Arg-NMec 5.5 169.0 73.5 
Azocasein 21.1 483.0 7.3 
Azocasein-urea 57.8 1362.0 2.2 
For experimental details see table 1 and section 2.2. Values are expressed as % 
Bbeef 
100.0 
79.0 
68.4 
5.0 
1.1 
B human 
100.0 
75.0 
74.4 
6.3 
1.9 
Table 3 
Residual activity of cathepsins L and S after reaction with irreversible inhibitors 
Inhibitors 
(lo-’ M) 
Z-Phe-Phe-CHNz 
Time of 
preincubation 
(min) 
5 
10 
20 
% residual activity 
Cathepsin L, Cathepsin S, 
rat liver beef spleen 
(1.7 x lo-‘M) (1.33 x lo-‘M) 
36 98 
15 90 
14 82 
Z-Phe-Ala-CHN2 5 49 85 
10 21 72 
20 16 68 
The activated enzymes were incubated with the inhibitors; the concentrations refer to 
the preincubation mixture. After 5, 10 and 20 min at room temperature the same 
volume of 2% azocasein in 6 M urea was added and the assay was incubated 30 min 
at 40°C to determine the residual activity of the enzyme 
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those of cathepsin S. The data are only valid for S from beef spleen with regard to the substrate 
substrate concentrations of 10 mM for Bz-Arg- specificity with low-M, substrates (table 2). On the 
NH2 (K,,, of 3 mM has been determined for rat other hand, the same split position between Met 
liver cathepsin L [5]) and 10pM for Z-Phe-Arg- and Arg in the hexapeptide Leu-Trp-Met-Arg-Phe- 
NMec (K,,, of 7 ,uM has been determined for Val has been detected for cathepsin L from rat 
cathepsin L from rat [9]). liver [14] and for cathepsin S from beef spleen [3]. 
Bz-Phe-Val-Arg-NMec was found to be the best 
of the synthetic substrates tested for beef cathepsin 
S, whereas Z-Phe-Arg-NMec is much better for 
cathepsin L (table 1). 
A comparison of the substrate specificity of 
cathepsins B from 3 species (table 1) showed no 
major differences. The molar activities of cathep- 
sin B from beef, rat and human are of the same 
order of magnitude with each substrate. The same 
is true of 10 additional peptides we tested with 
cathepsin B from these species (not shown). The 
biggest difference in the activities has been found 
with Z-Arg-Arg-NNapOMe; the enzymes from 
beef and human have a 3-fold higher value than 
the rat cathepsin B. These results show that there 
are almost no species differences in the catalytical 
properties of rat, beef and human cathepsin B 
(table 2). 
Similarly to cathepsin S, cathepsin N from beef 
spleen was also reported to have a lower activity 
towards Z-Phe-Arg-NMec than found for the rab- 
bit liver isoenzymes of cathepsin L [15]. However, 
it has not been established whether cathepsin N 
from beef spleen degrades azocasein [ 161. 
Cathepsins L and S differ in some physical pro- 
perties as well. Cathepsin S consists of a single 
chain of M, 24000 [l], whereas cathepsin L from 
rat has an Mr of 29000 and two chains can be 
separated after reduction by SDS-gel elec- 
trophoresis (Mr -24000 and -5000) [17]. We 
found that the enzymatic activity remained in the 
heavy chain of rat cathepsin L after removal of the 
light chain [17]. However, we could not establish 
differences in the substrate specificity of the two 
forms of cathepsin L (unpublished). 
Just as they differ in substrate specificity, 
cathepsins L and S differ in their sensitivity to in- 
hibitors. Peptide diazomethyl ketones exhibit a 
high degree of specificity for individual cysteine 
proteinases [ 121. Thus, Z-Phe-Phe-CHN2 has been 
found to react very fast and stoichiometrically with 
rat cathepsin L but only slowly with cathepsin B 
[6]. Z-Phe-Ala-CHNz is a potent inhibitor of 
cathepsins L and B from rat. As shown in table 3, 
these inhibitors cannot be regarded as potent in- 
hibitors of cathepsin S from beef spleen. 
Rat cathepsin L has isoelectric points in the 
range 5.5-6.1 [5] which are similar to those of rab- 
bit cathepsin L (pZ = 5.0-5.9) [7], but different to 
the pZ of 6.2-6.8 of beef spleen cathepsin S [I]. 
5. CONCLUSIONS 
4. DISCUSSION 
A comparison of the molar activities of rat 
cathepsin L and beef cathepsin S showed only 
small differences with azocasein as substrate, but 
major differences with low-M, substrates. In con- 
trast, cathepsins B from different species howed a 
distinctive pattern of relative activities with several 
substrates. It has been shown by HPLC analysis 
that rat, beef and human cathepsins B produce 
closely similar mixtures of peptides in the digestion 
of insulin B chain [13]. 
We detected differences in the substrate 
specificity and sensitivity towards inhibitors of 
cathepsin L from rat liver and cathepsin S from 
beef spleen. The pZ and Mr values of the enzymes 
differ [ 1,5]. The properties of high activity on Z- 
Phe-Arg-NMec and rapid inactivation by Z-Phe- 
Phe-CHN2 seem to be shared by cathepsin L from 
several other species, but are not seen with the beef 
spleen enzyme. For this reason, it may be more ap- 
propriate to retain the name ‘cathepsin S’ for the 
beef spleen enzyme. 
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